Terminal incorporation of 2̍ -deoxyadenosine into polyadenylate segments of polyadenylated RNA in g1-phase-arrested human t-lymphoblasts

Richard F. Kefford, Richard M. Fox, George E O Muscat, Peter B. Rowe

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

In the presence of the adenosine deaminase inhibitor erythro-9-[3-(2-hydroxynonyl)]adenine, μm concentrations of 2’-deoxy adenosine (dAdo) are toxic to nondividing human lymphoid cells and induce G1-phase arrest in T-leukemic lymphoblasts, effects which appear to be independent of ribonucleotide reductase inhibition by accumulated 2’-deoxyadenosine 5’-triphnsphate We sought to determine if 2’-deoxyadenosine 5’-triphosphate had effects similar to those of other cytotoxic adenosine analogues which are incorporated into polyadenylated RNA [poly(A)+ RNA]. In the presence of erythro-9-[3-(2-hydroxy-nonyl)]adenine, [8-14C]dAdo, at minimal cytostatic concentrations, was incorporated into the polyadenylate segments of cytoplasmic poly(A)+ RNA in the human T-leukemic lymphoblasi line CCRF-CEM, and 70% of incorporated dAdo was in the 3’-terminal position. No dAdo was found in enzyme hydrolysates of nonpolyadenylated regions of poly(A)+ RNA or of poly(A)-RNA. Enzymic hydrolysis of polyadenylated segments from labeled poly(A)+ RNA yielded adenosine:dAdo ratios of approximately 55:1.

Original languageEnglish
Pages (from-to)2252-2257
Number of pages6
JournalCancer Research
Volume43
Issue number5
Publication statusPublished - 1 May 1983
Externally publishedYes

    Fingerprint

Cite this